首页> 外文OA文献 >Quantitative Profiling of In Vivo-assembled RNA-Protein Complexes Using a Novel Integrated Proteomic Approach*
【2h】

Quantitative Profiling of In Vivo-assembled RNA-Protein Complexes Using a Novel Integrated Proteomic Approach*

机译:使用新型集成蛋白质组学方法对体内组装的RNA-蛋白质复合物进行定量分析*

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Identification of proteins in RNA-protein complexes is an important step toward understanding regulation of RNA-based processes. Because of the lack of appropriate methodologies, many studies have relied on the creation of in vitro assembled RNA-protein complexes using synthetic RNA and cell extracts. Such complexes may not represent authentic RNPs as they exist in living cells as synthetic RNA may not fold properly and nonspecific RNA-protein interactions can form during cell lysis and purification processes. To circumvent limitations in current approaches, we have developed a novel integrated strategy namely MS2 in vivo biotin tagged RNA affinity purification (MS2-BioTRAP) to capture bona fide in vivo-assembled RNA-protein complexes. In this method, HB-tagged bacteriophage protein MS2 and stem-loop tagged target or control RNAs are co-expressed in cells. The tight association between MS2 and the RNA stem-loop tags allows efficient HB-tag based affinity purification of authentic RNA-protein complexes. Proteins associated with target RNAs are subsequently identified and quantified using SILAC-based quantitative mass spectrometry. Here the 1.2 kb internal ribosome entry site (IRES) from lymphoid enhancer factor-1 mRNA has been used as a proof-of-principle target RNA. An IRES target was chosen because of its importance in protein translation and our limited knowledge of proteins associated with IRES function. With a conventionally translated target RNA as control, 36 IRES binding proteins have been quantitatively identified including known IRES binding factors, novel interacting proteins, translation initiation factors (eIF4A-1, eIF-2A, and eIF3g), and ribosomal subunits with known noncanonical actions (RPS19, RPS7, and RPL26). Validation studies with the small molecule eIF4A-1 inhibitor Hippuristanol shows that translation of endogenous lymphoid enhancer factor-1 mRNA is especially sensitive to eIF4A-1 activity. Our work demonstrates that MS2 in vivo biotin tagged RNA affinity purification is an effective and versatile approach that is generally applicable for other RNA-protein complexes.
机译:RNA-蛋白质复合物中蛋白质的鉴定是了解基于RNA的过程调控的重要一步。由于缺乏适当的方法,许多研究都依赖于使用合成RNA和细胞提取物创建体外组装的RNA-蛋白质复合物。此类复合物可能不代表真实的RNP,因为它们存在于活细胞中,因为合成RNA可能无法正确折叠,并且在细胞裂解和纯化过程中可能形成非特异性RNA-蛋白质相互作用。为了规避当前方法的局限性,我们开发了一种新颖的集成策略,即MS2体内生物素标记的RNA亲和纯化(MS2-BioTRAP),以捕获真正的体内组装的RNA-蛋白质复合物。在这种方法中,HB-标记的噬菌体蛋白MS2和茎-环标记的靶标或对照RNA在细胞中共表达。 MS2和RNA茎-环标签之间的紧密联系可以对真实的RNA-蛋白质复合物进行高效的基于HB标签的亲和纯化。随后使用基于SILAC的定量质谱法鉴定和定量与靶RNA相关的蛋白质。在这里,来自淋巴增强因子-1 mRNA的1.2 kb内部核糖体进入位点(IRES)已用作原理靶RNA。选择IRES靶标是因为其在蛋白质翻译中的重要性以及我们对与IRES功能相关的蛋白质的了解有限。以常规翻译的靶RNA作为对照,已定量鉴定了36种IRES结合蛋白,包括已知的IRES结合因子,新型相互作用蛋白,翻译起始因子(eIF4A-1,eIF-2A和eIF3g)以及具有已知非规范作用的核糖体亚基(RPS19,RPS7和RPL26)。小分子eIF4A-1抑制剂Hippuristanol的验证研究表明,内源性淋巴增强因子1 mRNA的翻译对eIF4A-1活性特别敏感。我们的工作表明,MS2体内生物素标记的RNA亲和纯化是一种有效且通用的方法,通常适用于其他RNA-蛋白质复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号